Inventor · disambiguated record
Jan J. Melenhorst
Also filed as: MELENHORST JAN · MELENHORST JAN J
6 granted patents·19 pending applications·52 citations·filing 2015–2025
81Inventor score
Top patents by PatentIndex Score
25 records- 0194US10829735B2Methods for improving the efficacy and expansion of immune cellsUNIV PENNSYLVANIA·Filed 2016·Granted Nov 10, 2020·14 cites·28 claims
- 0294US10273300B2Methods of making chimeric antigen receptor-expressing cellsUNIV PENNSYLVANIA·Filed 2015·Granted Apr 30, 2019·26 cites·28 claims
- 0391US12240884B2Methods for improving the efficacy and expansion of immune cellsNOVARTIS AG·Filed 2020·Granted Mar 4, 2025·2 cites·24 claims
- 0491US10774388B2Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereofNOVARTIS AG·Filed 2015·Granted Sep 15, 2020·7 cites·31 claims
- 0581US11747346B2Biomarkers predictive of cytokine release syndromeUNIV PENNSYLVANIA·Filed 2016·Granted Sep 5, 2023·3 cites·25 claims
- 0675US2025163123A1Therapeutic regimens for chimeric antigen receptor (car)-expressing cellsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0775US2023295296A1Methods of making chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0872US2024398913A1Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0970US2024408206A1Compositions and methods for treating b-lymphoid malignanciesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1069US2025230217A1Methods for improving the efficacy and expansion of immune cellsNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1169US2024076372A1Car t cell therapies with enhanced efficacyNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1267US2023139800A1Car t cell therapies with enhanced efficacyNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1366US2024288444A1Biomarkers predictive of cytokine release syndromeNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1462US2021172020A1Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereofNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1556US2019292257A1Methods of making chimeric antigen receptor - expressing cellsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1656US2020370012A1Methods of making chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1754US11896614B2Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2016·Granted Feb 13, 2024·0 cites·15 claims
- 1854US2021047405A1Car t cell therapies with enhanced efficacyNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1953US2021177896A1Therapeutic regimens for chimeric antigen receptor (car)- expressing cellsPORTER DAVID L·Filed 2017·Application pending·0 cites
- 2049US2023000916A1Anti-cd3 scfv and cytokine producing artificial antigen presenting cellsUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 2144US2021396739A1Biomarkers for evaluating car-t cells to predict clinical outcomeNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2243US2018258149A1Car t cell therapies with enhanced efficacyMOTZ GREGORY·Filed 2016·Application pending·0 cites
- 2339US2020371091A1Bcma-targeting chimeric antigen receptor, and uses thereofNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2439US2020087376A1Biomarkers and car t cell therapies with enhanced efficacyUNIV PENNSYLVANIA·Filed 2018·Application pending·0 cites
- 2539US2019151365A1Combination therapies of chimeric antigen receptors and pd-1 inhibitorsNOVARTIS AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jan J. Melenhorst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →